Metabolomics in Human Diseases and Health
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Advances in Metabolomics".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 73
Special Issue Editors
Interests: diabetes; lipids; biomarkers; lipoproteins; obesity; microbiota; sepsis; antibiotics
Interests: pharmacology; cardiac remodeling; cardiac regeneration; heart failure; sepsis; hypertension; atherogenesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metabolomics is a rapidly evolving field dedicated to the comprehensive identification and analysis of small molecules or metabolites present in various biological samples, including cells, tissues, and bodily fluids. Unlike other ‘omics’ technologies, metabolomics offers a direct reflection of the metabolic activity and status of cells and tissue, making it a promising tool for understanding molecular phenotypes. This field employs both untargeted and targeted approaches, with mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy being the primary analytical techniques. In the context of human health, metabolomics plays a pivotal role in identifying metabolic patterns associated with various diseases such as cancer, diabetes mellitus, cardiovascular diseases, and neurodegenerative disorders.
These unique signatures can serve as diagnostic markers, facilitating early disease detection, monitoring disease progression, and guiding personalized treatment strategies. Furthermore, metabolomics contributes to a deeper understanding of disease mechanisms, paving the way for the development of novel therapeutic interventions and precision-targeted treatments. It therefore holds significant potential for advancing our understanding of human diseases and improving patient care outcomes, offering valuable insights into diagnosis and prognosis.
The aim of this Special Issue, titled "Metabolomics in Human Diseases and Health", is to provide an in-depth overview of the field, focusing on the aspects mentioned above. We welcome original research and review articles that explore these themes and contribute to the advancement of metabolomics in human health.
Dr. Dimitris Kounatidis
Dr. Iordanis Mourouzis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolomics
- NAFLD
- biomarkers
- obesity
- mass spectrometry
- NMR spectroscopy
- diabetes mellitus
- cancer
- cardiovascular diseases
- neurodegenerative diseases
